Renal-hepatic syndrome is a complex of disorders resulting from simultaneous damage to the liver and kidneys. This pathology is the result of a negative impact on both organs. Thus, the syndrome does not describe a disease, but rather speaks of the condition of a patient who has disturbances in both liver and kidney function.
Renal-hepatic syndrome can develop under the following conditions: chronic or acute hepatitis, cirrhosis of the liver, alcoholic hepatitis, acalculous cholecystitis, inflammation of periarticular tissues. First of all, the increase in mortality among patients with PID is due to late diagnosis and improper treatment. Therefore, effective prevention is determined by government regulation. But such an assessment is not yet widespread. The first risk group includes young people. From 20 to 30 years. They have a high risk of disease because, first of all, they do not have the necessary experience in seeking medical help. Therefore, it is always necessary to maintain a healthy lifestyle and diet, work and rest schedule, timely vaccination against hepatitis B and viral hepatitis D. The most common cause of death in patients with PID is considered to be progression of the disease to the terminal stage (58.8%), bleeding from varicose veins. dilated veins of the esophagus and stomach (25.3%), obstructive intestinal obstruction (8.5%) and fulminant hepatitis B/D (7.4%).